Meiji Yasuda Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14M Sell
15,242
-232
-1% -$235K 0.7% 25
2025
Q4
$16.6M Sell
15,474
-361
-2% -$345K 0.8% 22
2025
Q3
$12.1M Sell
15,835
-347
-2% -$258K 0.58% 32
2025
Q2
$12.6M Sell
16,182
-9,696
-37% -$7.53M 0.63% 30
2025
Q1
$21.4M Sell
25,878
-521
-2% -$434K 0.86% 21
2024
Q4
$20.4M Sell
26,399
-638
-2% -$528K 0.78% 21
2024
Q3
$24M Buy
27,037
+510
+2% +$459K 0.91% 17
2024
Q2
$24M Buy
26,527
+1,427
+6% +$1.14M 0.98% 14
2024
Q1
$19.5M Buy
25,100
+857
+4% +$610K 0.83% 19
2023
Q4
$14.1M Sell
24,243
-759
-3% -$443K 0.64% 31
2023
Q3
$13.4M Buy
25,002
+11,217
+81% +$5.78M 0.63% 28
2023
Q2
$6.46M Sell
13,785
-428
-3% -$179K 0.32% 100
2023
Q1
$4.88M Sell
14,213
-6,733
-32% -$2.27M 0.25% 123
2022
Q4
$7.66K Sell
20,946
-427
-2% -$151K 0.37% 79
2022
Q3
$6.91M Sell
21,373
-603
-3% -$191K 0.4% 70
2022
Q2
$7.13M Sell
21,976
-12,494
-36% -$3.75M 0.41% 54
2022
Q1
$9.87M Sell
34,470
-1,576
-4% -$406K 0.54% 41
2021
Q4
$9.96M Sell
36,046
-9,387
-21% -$2.38M 0.62% 31
2021
Q3
$10.5M Sell
45,433
-1,316
-3% -$325K 0.75% 25
2021
Q2
$10.7M Sell
46,749
-2,086
-4% -$419K 0.51% 45
2021
Q1
$9.12M Buy
48,835
+15,488
+46% +$3.03M 0.67% 31
2020
Q4
$5.63M Buy
33,347
+4,470
+15% +$667K 0.56% 45
2020
Q3
$4.27M Sell
28,877
-6,810
-19% -$1.05M 0.47% 55
2020
Q2
$5.86M Buy
35,687
+22,270
+166% +$3.42M 0.56% 45
2020
Q1
$1.86M Sell
13,417
-29,125
-68% -$4M 0.35% 71
2019
Q4
$5.59M Buy
42,542
+5,170
+14% +$599K 0.47% 55
2019
Q3
$4.18M Buy
37,372
+210
+0.6% +$23.4K 0.34% 76
2019
Q2
$4.12M Sell
37,162
-7,610
-17% -$896K 0.35% 72
2019
Q1
$5.81M Sell
44,772
-2,393
-5% -$291K 0.49% 57
2018
Q4
$5.46M Sell
47,165
-9,857
-17% -$1.1M 0.51% 51
2018
Q3
$6.12M Sell
57,022
-330
-0.6% -$33K 0.5% 53
2018
Q2
$4.89M Buy
57,352
+980
+2% +$80.5K 0.43% 63
2018
Q1
$4.36M Buy
56,372
+2,270
+4% +$183K 0.41% 70
2017
Q4
$4.57M Buy
54,102
+1,120
+2% +$95.3K 0.43% 64
2017
Q3
$4.53M Sell
52,982
-100
-0.2% -$8.2K 0.44% 61
2017
Q2
$4.37M Sell
53,082
-1,950
-4% -$159K 0.45% 61
2017
Q1
$4.63M Buy
55,032
+2,830
+5% +$227K 0.49% 54
2016
Q4
$3.84M Buy
52,202
+1,440
+3% +$107K 0.43% 65
2016
Q3
$4.07M Buy
50,762
+7,250
+17% +$580K 0.48% 59
2016
Q2
$3.43M Buy
43,512
+24,150
+125% +$1.82M 0.49% 61
2016
Q1
$1.39M Buy
19,362
+760
+4% +$57.5K 0.32% 79
2015
Q4
$1.57M Buy
18,602
+1,730
+10% +$144K 0.36% 75
2015
Q3
$1.41M Buy
16,872
+2,515
+18% +$212K 0.35% 73
2015
Q2
$1.2M Buy
14,357
+370
+3% +$28.2K 0.28% 91
2015
Q1
$1.02M Buy
13,987
+230
+2% +$16.4K 0.25% 104
2014
Q4
$949K Sell
13,757
-1,630
-11% -$110K 0.23% 117
2014
Q3
$998K Sell
15,387
-400
-3% -$25.3K 0.23% 108
2014
Q2
$981K Sell
15,787
-3,316
-17% -$198K 0.2% 113
2014
Q1
$1.12M Sell
19,103
-3,090
-14% -$172K 0.24% 100
2013
Q4
$1.13M Buy
22,193
+2,320
+12% +$116K 0.24% 101
2013
Q3
$1M Buy
19,873
+529
+3% +$27.7K 0.23% 108
2013
Q2
$956K Buy
+19,344
New +$1.05M 0.23% 106

Other funds holding LLY

Meiji Yasuda Asset Management's LLY Position: Q1 2026 in Review

Meiji Yasuda Asset Management reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $235K and leaving 15,242 shares worth $14M. The position accounts for 0.7% of the portfolio, ranked #25.

Meiji Yasuda Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $24M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Meiji Yasuda Asset Management held 15,242 shares of Eli Lilly worth $14M as of Q1 2026.
  • Meiji Yasuda Asset Management sold 232 Eli Lilly shares in Q1 2026, an estimated $235K.
  • Eli Lilly made up 0.7% of Meiji Yasuda Asset Management's portfolio in Q1 2026, its #25 holding.
  • Meiji Yasuda Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Meiji Yasuda Asset Management's Eli Lilly position peaked at $24M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q1 2026, filed 14 May 2026.